Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Treatments to Raise HDL Cholesterol May Not Reduce Heart Attack Risk

By LabMedica International staff writers
Posted on 31 May 2012
Elevated levels of HDL (high-density lipoprotein) cholesterol have long been recognized as a biomarker for reduced risk of heart disease, however data published in a recent paper found that drug treatment to raise levels of HDL cholesterol might not lower an individual’s heart attack risk.

Investigators at Harvard University Medical School (Boston, MA, USA) used a statistical approach based on “Mendelian randomization” to analyze nucleotide polymorphism (SNP) data from more than 170,000 individuals. The SNPs were in genes linked to HDL metabolism. With such a large number of cases, individual variations evened out and any differences could be attributed to the specific SNPs under investigation.

Results published in the May 17, 2012, online edition of the journal the Lancet revealed that individuals carrying a particular variation in the gene for the enzyme endothelial lipase had HDL levels that were elevated by about six mg/dL, or 10% - representing a level of HDL cholesterol that would be expected to decrease heart attack risk by about 13%. However, this population showed no difference in risk of heart disease compared to those without the variant.

“It has been assumed that if a patient, or group of patients, did something to cause their HDL levels to go up, then you can safely assume that their risk of heart attack will go down,” said senior author Dr. Sekar Kathiresan, associate professor of medicine at Harvard Medical School. “This work fundamentally questions that. We know that HDL is a great biomarker – it is quite useful in identifying individuals at higher risk of having a heart attack in the future. But we have shown that you cannot assume that raising HDL by any mechanism will help patients. Perhaps other mechanisms exist that can lower risk, but we will need to keep searching for them.”

Related Links:

Harvard University Medical School



Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Biological Indicator Vials
BI-O.K.
New
Fecal DNA Extraction Kit
QIAamp PowerFecal Pro DNA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.